References
- Tate JE, Burton AH, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136–141.
- Tate JE, Burton AH, Boschi-Pinto C, et al. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62(suppl 2):S96–S105.
- Soares-Weiser K, MacLehose H, Bergman H, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use [Internet]. In: Soares-Weiser K, editor. Cochrane database of systematic reviews. Chichester (UK): John Wiley & Sons, Ltd; 2012 [cited 2016 May 5]. Available from: http://doi.wiley.com/10.1002/14651858.CD008521.pub3
- Dey A, Wang H, Menzies R, et al. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Med J Aust. 2012;197(8):453–457.
- Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014. Vaccine. 2015;33(18):2097–2107.
- Cortes JE, Curns AT, Tate JE, et al. Rotavirus vaccine and health care utilization for Diarrhea in U.S. children. N Engl J Med. 2011;365(12):1108–1117.
- Simonsen L, Viboud C, Elixhauser A, et al. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis. 2005;192(Suppl s1):SS36–SS43.
- Weintraub ES, Baggs J, Duffy J, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370:513–519.
- Carlin JB, Macartney KK, Lee KJ, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia’s national immunization program. Clin Infect Dis. 2013;57(10):1427–1434.
- Sharma R, Hudak ML, Premachandra BR, et al. Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J. 2002;21(12):1099–1105.
- Newman RD, Grupp-Phelan J, Shay DK, et al. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics. 1999;103(1):E3.
- Van Der Wielen M, Van Damme P. Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the rotavirus efficacy and safety trial. Eur J Clin Microbiol Infect Dis. 2008;27(7):495–501.
- Omenaca F, Sarlangue J, Szenborn L, et al. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European infants. Pediatr Infect Dis J. 2012;31(5):487–493.
- Roue JM, Nowak E, Le Gal G, et al. Impact of rotavirus vaccine on premature infants. Clin Vaccine Immunol. 2014;21(10):1404–1409.
- Thrall S, Doll MK, Nhan C, et al. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units. Vaccine. 2015;33(39):5095–5102.
- Smith CK, McNeal MM, Meyer NR, et al. Rotavirus shedding in premature infants following first immunization. Vaccine. 2011;29(45):8141–8146.
- Rivera L, Peña LM, Stainier I, et al. Horizontal transmission of a human rotavirus vaccine strain–a randomized, placebo-controlled study in twins. Vaccine. 2011;29(51):9508–9513.
- Payne DC, Edwards KM, Bowen MD, et al. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics. 2010;125(2):e438–e441.
- Stumpf KA, Thompson T, Sánchez PJ. Rotavirus vaccination of very low birth weight infants at discharge from the NICU. Pediatrics. 2013;132(3):e662–e665.
- Monk H, Motsney A, Wade K. Safety of rotavirus vaccine in the NICU. Pediatrics. 2014;133(6):e1555–e1560.
- Jaques SC, Ogley L, Donovan D, et al. Rotavirus immunisation in NICU: a 1-year experience in a UK tertiary neonatal surgical unit postvaccine introduction. Arch Dis Child Fetal Neonatal Ed. 2015;100(2):F186–F187.
- Kilich EAM, Anthony M. Letter: rotavirus vaccination in preterm infants: a neonatal guidance chart to aid timely immunisation. Arch Dis Child Fetal Neonatal Ed. 2015;100(5):F465.